2GY Stock Chart & Stats
€5.85
€0.05(0.85%)
At close: 4:00 PM EST
€5.85
€0.05(0.85%)
Day’s Range― - ―
52-Week Range€4.96 - €6.35
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€749.38M
Enterprise Value€348.64K
Total Cash (Recent Filing)€39.82B
Total Debt (Recent Filing)€234.56B
Price to Earnings (P/E)288.6
Beta0.37
Next Earnings
Aug 06, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.85
Shares Outstanding127,320,915
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-2.94
Price to Book (P/B)0.85
Price to Sales (P/S)0.38
P/FCF Ratio4.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.69
Revenue Forecast (FY)€1.96B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & Service RevenuePHC's business mixes capital equipment with recurring consumables and services tied to installed diagnostic and lab instruments. That recurring revenue supports steady cash flow and customer stickiness, making top-line and cash generation less cyclical over a multi‑quarter horizon.
Improving Revenue GrowthA meaningful pickup in revenue (+12.9% latest year) signals expanding product adoption across diagnostics, life sciences and medical equipment. Sustained top‑line improvement can drive operating leverage, aid margin recovery and materially improve debt paydown prospects over months.
Consistent Positive Free Cash FlowPHC has produced positive operating and free cash flow even in loss years, and FCF stepped up materially recently. Durable cash conversion supports reinvestment, service of debt, and shareholder payouts, and reduces reliance on external funding for near‑term strategic initiatives.
Bears Say
Volatile ProfitabilityEarnings volatility undermines forecasting and capital allocation: swings from multi-year losses to a one‑year profit then near break‑even raise doubt about sustainable operating margins. This instability complicates planning for R&D, capex and deleveraging over the medium term.
Elevated Leverage Remains MeaningfulAlthough leverage has improved from higher levels, a debt/equity around 1.45x leaves the firm sensitive to cash flow swings and interest costs. This reduces financial flexibility for M&A or cyclical downturns and increases reliance on sustained FCF or refinancing capacity over coming quarters.
Very Low Returns / Near Zero ROEROE near zero and a tiny net margin indicate limited profitability versus capital employed. Low returns constrain internal funding for growth, weaken the buffer against shocks, and make it harder to materially improve leverage or invest in margin-enhancing initiatives without external capital.
PHC Holdings Corp. News
2GY FAQ
What was PHC Holdings Corp.’s price range in the past 12 months?
PHC Holdings Corp. lowest stock price was €4.96 and its highest was €6.35 in the past 12 months.
What is PHC Holdings Corp.’s market cap?
PHC Holdings Corp.’s market cap is €749.38M.
When is PHC Holdings Corp.’s upcoming earnings report date?
PHC Holdings Corp.’s upcoming earnings report date is Aug 06, 2026 which is in 7 days.
How were PHC Holdings Corp.’s earnings last quarter?
PHC Holdings Corp. released its earnings results on May 13, 2026. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of €0.085 by -€0.093.
Is PHC Holdings Corp. overvalued?
According to Wall Street analysts PHC Holdings Corp.’s price is currently Overvalued.
Does PHC Holdings Corp. pay dividends?
PHC Holdings Corp. does not currently pay dividends.
What is PHC Holdings Corp.’s EPS estimate?
PHC Holdings Corp.’s EPS estimate is 0.11.
How many shares outstanding does PHC Holdings Corp. have?
PHC Holdings Corp. has 127,320,915 shares outstanding.
What happened to PHC Holdings Corp.’s price movement after its last earnings report?
PHC Holdings Corp. reported an EPS of -€0.009 in its last earnings report, missing expectations of €0.085. Following the earnings report the stock price went down -1.386%.
Which hedge fund is a major shareholder of PHC Holdings Corp.?
Currently, no hedge funds are holding shares in DE:2GY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PHC Holdings Corp.
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
Technical Analysis
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―